Definitive Healthcare Q2 FY26 net loss narrows to $7.5 million; revenue drops 9% to $55.2 million - DH News | Rallies
Definitive Healthcare Q2 FY26 net loss narrows to $7.5 million; revenue drops 9% to $55.2 million D DH • 2026-08-10 Outlook
Guided Q3 revenue at USD 54-55 million; forecast full-year revenue of USD 220-222 million with non-GAAP adjusted EBITDA of USD 57-59 million.
Q2 results
Definitive Healthcare Q2 revenue fell 9% year over year to USD 55.2 million; GAAP net loss narrowed to USD 7.5 million from USD 9.3 million.
Non-GAAP adjusted EBITDA slid to USD 14.6 million from USD 18.7 million; margin compressed 5 percentage points to 26%.
Operating cash flow was USD 11.5 million; non-GAAP unlevered free cash flow totaled USD 11.6 million.
Product launch and business trends
Launched Turbo, an AI-powered healthcare intelligence platform; highlighted improving net dollar retention and win-back momentum, including a six-figure three-year enterprise return.
•
2026-08-10
DH•
